GS Biotech

Hangzhou, China · Founded 2021 · Privately Held (backing)

Developer of furans bio-based materials designed to reduce carbon emissions. GS Biotech is based in Hangzhou, China and was founded in 2021. Its last reported valuation was $417 million in Feb 2025. It has raised $56.2 million.

Last reported valuation
$417.3M
Oct 2026
Priced at
—
Total raised
$56.2M
Last round
—

Who backs GS Biotech?

15 investors
InvestorType
Plug and Play Tech Center—
Puhua CapitalOther
Legend CapitalVenture capital
5Y CapitalOther
Eastern Bell Venture CapitalVenture capital
Hangzhou CapitalOther
Country Garden Venture CapitalOther
CITIC Jingshi Investment—
Hangzhou Yuhang State-owned Capital Investment and Operation Group—
Junsan Capital—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

GS Biotech investors

15 investors are on record for GS Biotech, including Plug and Play Tech Center, Puhua Capital, Legend Capital and 5Y Capital.

Free account
More of GS Biotech with a free account
  • ·The complete investor list: 15 names
  • ·Watch GS Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like GS Biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View